Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: Findings for type 2 diabetics with nonproliferative retinopathy

Ophthalmologica

Volumn 223, Issue 5, 2009, Pages 292-297

  Nunes, Sandrina ^a   Pires, Isabel ^a,b   Rosa, Andreia ^a,b   Duarte, Lilianne ^a   Bernardes, Rui ^a   Cunha Vaz, José ^a,b,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c ASSOCIATION FOR INNOVATION AND BIOMEDICAL RESEARCH ON LIGHT AND IMAGE AIBILI   (Portugal)

Author keywords

Color fundus photography; Diabetic retinopathy; Image co registration; Microaneurysm count; Microaneurysm disappearance rate; Microaneurysm formation rate; Microaneurysm turnover

Indexed keywords

HEMOGLOBIN A1C; HYDROCHLOROTHIAZIDE; NIFEDIPINE; ORAL ANTIDIABETIC AGENT; RAMIPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLOR FUNDUS PHOTOGRAHY; CONTROL GROUP; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; EYE CARE; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANEURYSM; MICROANEURYSM TURNOVER; NON INSULIN DEPENDENT DIABETES MELLITUS; RETINA MACULA EDEMA; VISUAL ACUITY;

ADULT; AGED; ANEURYSM; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MACULAR EDEMA; MALE; MIDDLE AGED; PHOTOGRAPHY; RETINAL VESSELS; RETROSPECTIVE STUDIES;

EID: 64549111668     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000213639     Document Type: Article

References (16)

1. Cunha-Vaz J: Characterization and relevance of different diabetic retinopathy phenotypes. Dev Ophthalmol 2007; 39: 13-30.
2. Kohner EM, Stratton IM, Aldington SJ, Turner RC, Matthews DR: Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group. Diabetologia 1999; 42: 1107-1112.
3. Hove MN, Kristensen JK, Lauritzen T, Bek T: The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes. Acta Ophthalmol Scand 2006; 84: 619-623.
4. Klein R, Klein B, Moss SE, Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995; 102: 7-16.
5. Hellstedt T, Immonen I: Disappearance and formation rates of microaneurysms in early diabetic retinopathy. Br J Ophthalmol 1996; 80: 135-139.
6. Kohner EM: Microvascular disease: what does the UKPDS tell us about diabetic reti-nopathy? Diabet Med 2008; 25(suppl 2):20-24.
7. Vander JM: Diabetic retinopathy; in Ho AC, Brown GC, McNamara A, Recchia FM, Re-gillio CD, Vander JF (eds): Retina: Color Atlas and Synopsis of Clinical Ophthalmology. Madrid, McGraw-Hill, 2003, pp 54-75.
8. Early Treatment Diabetic Retinopathy Study Research Group: Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. ETDRS report number 2. Ophthalmology 1987; 94: 761-774.
9. Early Treatment Diabetic Retinopathy Study Research Group: Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology 1991; 98: 767-785.
10. Fleiss JL: Design and Analysis of Clinical Experiments. New York, John Wiley & Sons, 1986.
11. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
12. Early Treatment Diabetic Retinopathy Study Research Group: Fundus photographic risk factors for progression of diabetic retinopa-thy. ETDRS report number 12. Ophthalmology 1991; 98(suppl):823-833.
13. Lobo C, Bernardes R, Figueira JP, de Abreu JR, Cunha-Vaz JG: Three-year follow-up of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy. Arch Ophthalmol 2004; 122: 211-217.
14. Csaky KG, Richman EA, Ferris FL: Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium. Invest Ophthalmol Vis Sci 2008; 49: 479-489.
15. Sharp PF, Olson J, Strachan F, Hipwell J, Ludbrook A, man K, Grant A, Waugh N, McHardy K, For-rester JV: The value of digital imaging in diabetic retinopathy. Health Technol Assess 2003; 7: 1-119.
16. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UK-PDS 33). Lancet 1998; 352: 837-853.